Multi-Stakeholder Policy

View in Japanese

We, Chugai Pharmaceutical Co., Ltd., will strive to work appropriately together with multi-stakeholders in a context where the creation of value not only with our shareholders, but employees, business partners, customers, creditors, local communities, and other diverse stakeholders is important in our business management.　We believe that the appropriate distribution of revenue and outcomes generated through value creation and productivity improvement to multi-stakeholders leads to maintaining the momentum of wage increases and the sustainable development of the economy. Therefore, we will proceed with the following initiatives, considering the importance of returning to our employees as well as consideration for our business partners.

Return to Employees

We will focus on the strategic allocation of management resources to growth areas, the development of employee capabilities, and skill enhancement to achieve sustainable growth and productivity improvement, maximizing added value. Based on the revenue and outcomes generated, we will raise wages in accordance with the Principles of Wage Determination and our company's situation. Additionally, we will actively engage in initiatives such as education and training to enhance employee engagement and further improve productivity, aiming for sustainable returns to employees. Specifically, we will engage in sincere dialogue between labor and management regarding wage increases, continuously work on raising base annual income, and foster a culture that encourages employees' proactive growth and challenges, leading to a virtuous cycle of human capital management.

Respect and Consideration for our Business Partners

We will continue to comply with the Partnership Building Declaration. If the publication of the Partnership Building Declaration is discontinued, we will voluntarily withdraw the publication of the Multi-Stakeholder Policy.

We will steadily proceed with these initiatives while confirming the status of their implementation.

December 20, 2024
Chugai Pharmaceutical Co., Ltd.
Representative Osamu Okuda